NCT02339324
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
2,209 public trials
376 recruiting studies
Melanoma trial results
NCT03329755
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Hôpital Saint André, CHU de Bordeaux Bordeaux, France
- Institut claudius regaud IUCT ONCOPOLE Toulouse, France
NCT01597908
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Gilbert, Arizona, United States
- Novartis Investigative Site Beverly Hills, California, United States
- Novartis Investigative Site San Francisco, California, United States
NCT04760080
- Conditions
- Dermatology and Oncology, Melanoma, Neoplasms, +10 more
- Locations
-
- Centre Hospitalier Lyon Sud Pierre-Bénite, France
NCT01584648
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Novartis Investigative Site Scottsdale, Arizona, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Fort Myers, Florida, United States
NCT02902042
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Klinikum Augsburg Süd Augsburg, Bavaria, Germany
- Klinikum rechts der Isar München, Bavaria, Germany
- Klinikum Nürnberg Nord Nuremberg, Bavaria, Germany
NCT03163433
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Aarhus University Hospital, Department of Oncology Aarhus, Denmark
Completed
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
NCT01321437
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +13 more
- Locations
-
- Chao Family Comprehensive Cancer Center Orange, California, United States
NCT02493361
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of San Francisco, California San Francisco, California, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Novartis Investigative Site Essen, Germany
- Novartis Investigative Site Lausanne, Switzerland
- Novartis Investigative Site Zurich, Switzerland